Par Drugs (India) Price on June 26, 2023
| PAR Stock | 104.64 5.51 5.00% |
Below is the normalized historical share price chart for Par Drugs And extending back to May 30, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Par Drugs stands at 104.64, as last reported on the 1st of March, with the highest price reaching 104.64 and the lowest price hitting 104.64 during the day.
If you're considering investing in Par Stock, it is important to understand the factors that can impact its price. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of -0.39, which implies the firm had a -0.39 % return per unit of risk over the last 3 months. Par Drugs And exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Par Drugs' Coefficient Of Variation of (382.92), risk adjusted performance of (0.18), and Variance of 28.01 to confirm the risk estimate we provide.
The current year's Total Stockholder Equity is expected to grow to about 1 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 11.2 M. . Par Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 230.8853 | 50 Day MA 184.8476 | Beta 0.135 |
Par |
Sharpe Ratio = -0.3895
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PAR |
Estimated Market Risk
| 4.64 actual daily | 41 59% of assets are more volatile |
Expected Return
| -1.81 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.39 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Par Drugs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Par Drugs by adding Par Drugs to a well-diversified portfolio.
Price Book 1.4007 | Book Value 78.685 | Enterprise Value 1.2 B | Enterprise Value Ebitda 4.1505 | Price Sales 1.269 |
Par Drugs Valuation on June 26, 2023
It is possible to determine the worth of Par Drugs on a given historical date. On June 26, 2023 Par was worth 210.45 at the beginning of the trading date compared to the closed value of 204.85. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Par Drugs stock. Still, in general, we apply an absolute valuation method to find Par Drugs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Par Drugs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Par Drugs' related companies.
| Open | High | Low | Close | Volume | |
| 207.00 | 211.00 | 202.55 | 210.45 | 15,646 | |
06/26/2023 | 210.45 | 216.00 | 201.00 | 204.85 | 11,464 |
| 204.85 | 213.00 | 204.85 | 209.55 | 13,560 |
| Backtest Par Drugs | | | Par Drugs History | | | Par Drugs Valuation | Previous | Next |
Par Drugs Trading Date Momentum on June 26, 2023
| On June 27 2023 Par Drugs And was traded for 209.55 at the closing time. The highest price during the trading period was 213.00 and the lowest recorded bid was listed for 204.85 . The volume for the day was 13.6 K. This history from June 27, 2023 contributed to the next trading day price growth. The trading delta at closing time to the next closing price was 2.29% . The trading delta at closing time to the current price is 2.27% . |
Par Drugs And Fundamentals Correlations and Trends
By evaluating Par Drugs' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Par Drugs' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Par financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Par Drugs Stock history
Par Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Par is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Par Drugs And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Par Drugs stock prices may prove useful in developing a viable investing in Par Drugs
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.2 M | 11.2 M | |
| Net Income Applicable To Common Shares | 106 M | 65.2 M |
Par Drugs Quarterly Net Working Capital |
|
Par Drugs Stock Technical Analysis
Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Par Drugs Period Price Range
Low | March 1, 2025
| High |
0.00 | 0.00 |
Par Drugs And cannot be verified against its exchange. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Par Drugs March 1, 2025 Market Strength
Market strength indicators help investors to evaluate how Par Drugs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Par Drugs shares will generate the highest return on investment. By undertsting and applying Par Drugs stock market strength indicators, traders can identify Par Drugs And entry and exit signals to maximize returns
Par Drugs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Par Drugs' price direction in advance. Along with the technical and fundamental analysis of Par Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Par to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.18) | |||
| Jensen Alpha | (1.38) | |||
| Total Risk Alpha | (1.23) | |||
| Treynor Ratio | (2.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Par Stock analysis
When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |